Literature DB >> 30257602

The long non-coding RNA CRNDE competed endogenously with miR-205 to promote proliferation and metastasis of melanoma cells by targeting CCL18.

Libin Xu1, Yu Zhang2, Zhenguo Zhao1, Zhengju Chen3, Zheng Wang4, Songfeng Xu1, Xinxin Zhang1, Ting Liu1, Shengji Yu1.   

Abstract

Melanoma was the most malignant skin neoplasm with an increasing morbidity around the world. Although new immunotherapies and targeted therapies have emerged recently, the long-term survival of melanoma patients still remains low. To reveal effective diagnostic methods and therapeutic strategies, the potential mechanism of melanoma is urgently needed to be studied. Long non-coding RNAs (lncRNAs) have become an important regulatory factor in the occurrence and development of cancer, and it can be used as a new prognostic and diagnostic marker. In this study, we aimed to inspect the effects of lncRNA colorectal neoplasia differentially expressed (CRNDE) on the melanoma cell viability, invasion and migration. After microarray analysis, 106 dysregulated lncRNAs and 1187 abnormally expressed mRNAs were screened out. Further, the lncRNA CRNDE and CCL18 expression in melanoma tissues and cell lines were examined. It was determined that they were both overexpressed in melanoma tissues and cell lines. The down-regulation of lncRNA CRNDE and CCL18 induced melanoma cell apoptosis and inhibited cell viability. Then, miR-205 which had binding site with lncRNA CRNDE and CCL18 was involved in the next experiment, and it was down-regulated in melanoma that negatively correlated with lncRNA CRNDE expression. In addition, overexpression of miR-205 results in the restore of cell viability and aggressiveness. In conclusion, LncRNA CRNDE promotes the migration and invasion of melanoma by sponging miR-205 and releasing CCL18.

Entities:  

Keywords:  CCL18; Mir-205; lncRNA CRNDE; melanoma

Mesh:

Substances:

Year:  2018        PMID: 30257602      PMCID: PMC6226222          DOI: 10.1080/15384101.2018.1526602

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  21 in total

1.  CTGF secreted by mesenchymal-like hepatocellular carcinoma cells plays a role in the polarization of macrophages in hepatocellular carcinoma progression.

Authors:  Tian-Tian Wang; Ji-Hang Yuan; Jin-Zhao Ma; Wen-Jun Yang; Xiao-Ning Liu; Yu-Peng Yin; Yan Liu; Wei Pan; Shu-Han Sun
Journal:  Biomed Pharmacother       Date:  2017-09-12       Impact factor: 6.529

2.  CCL18 promotes epithelial-mesenchymal transition, invasion and migration of pancreatic cancer cells in pancreatic ductal adenocarcinoma.

Authors:  Fanbin Meng; Wan Li; Changling Li; Zhigang Gao; Kejian Guo; Shaowei Song
Journal:  Int J Oncol       Date:  2014-12-10       Impact factor: 5.650

3.  Long noncoding RNA MALAT1 promotes uveal melanoma cell growth and invasion by silencing of miR-140.

Authors:  Lei Sun; Peng Sun; Qi-Ying Zhou; Xiangchun Gao; Qing Han
Journal:  Am J Transl Res       Date:  2016-09-15       Impact factor: 4.060

4.  MicroRNA-211 Loss Promotes Metabolic Vulnerability and BRAF Inhibitor Sensitivity in Melanoma.

Authors:  Anupama Sahoo; Sanjaya K Sahoo; Piyush Joshi; Bongyong Lee; Ranjan J Perera
Journal:  J Invest Dermatol       Date:  2018-08-01       Impact factor: 8.551

5.  LncRNA UCA1-miR-507-FOXM1 axis is involved in cell proliferation, invasion and G0/G1 cell cycle arrest in melanoma.

Authors:  Yanping Wei; Qianqian Sun; Lindong Zhao; Jianbo Wu; Xiaonan Chen; Yuanyuan Wang; Wenqiao Zang; Guoqiang Zhao
Journal:  Med Oncol       Date:  2016-07-07       Impact factor: 3.064

6.  CRNDE Promotes Malignant Progression of Glioma by Attenuating miR-384/PIWIL4/STAT3 Axis.

Authors:  Jian Zheng; Xiaobai Liu; Ping Wang; Yixue Xue; Jun Ma; Chengbin Qu; Yunhui Liu
Journal:  Mol Ther       Date:  2016-04-08       Impact factor: 11.454

7.  The lncRNA CRNDE promotes colorectal cancer cell proliferation and chemoresistance via miR-181a-5p-mediated regulation of Wnt/β-catenin signaling.

Authors:  Peng Han; Jing-Wen Li; Bo-Miao Zhang; Jia-Chen Lv; Yong-Min Li; Xin-Yue Gu; Zhi-Wei Yu; Yun-He Jia; Xue-Feng Bai; Li Li; Yan-Long Liu; Bin-Bin Cui
Journal:  Mol Cancer       Date:  2017-01-13       Impact factor: 27.401

8.  Long noncoding RNA CRNDE stabilized by hnRNPUL2 accelerates cell proliferation and migration in colorectal carcinoma via activating Ras/MAPK signaling pathways.

Authors:  Huijuan Jiang; Yiqing Wang; Meiling Ai; Haowei Wang; Zhijiao Duan; Huanan Wang; Li Zhao; Jiang Yu; Yanqing Ding; Shuang Wang
Journal:  Cell Death Dis       Date:  2017-06-08       Impact factor: 8.469

9.  The lincRNA MIRAT binds to IQGAP1 and modulates the MAPK pathway in NRAS mutant melanoma.

Authors:  Martina Sanlorenzo; Igor Vujic; Rosaura Esteve-Puig; Kevin Lai; Marin Vujic; Kevin Lin; Christian Posch; Michelle Dimon; Adrian Moy; Mitchell Zekhtser; Katia Johnston; Deborah Gho; Wilson Ho; Abhinay Gajjala; Juan Oses Prieto; Alma Burlingame; Adil Daud; Klemens Rappersberger; Susana Ortiz-Urda
Journal:  Sci Rep       Date:  2018-07-19       Impact factor: 4.379

10.  Long non-coding RNA CASC15 regulates gastric cancer cell proliferation, migration and epithelial mesenchymal transition by targeting CDKN1A and ZEB1.

Authors:  Qiong Wu; Shihao Xiang; Jiali Ma; Pingping Hui; Ting Wang; Wenying Meng; Min Shi; Yugang Wang
Journal:  Mol Oncol       Date:  2018-05-09       Impact factor: 6.603

View more
  12 in total

1.  A novel 7‑hypoxia‑related long non‑coding RNA signature associated with prognosis and proliferation in melanoma.

Authors:  Yi Luo; Tinghao Li; Hengguang Zhao; Aijun Chen
Journal:  Mol Med Rep       Date:  2022-06-15       Impact factor: 3.423

Review 2.  Macrophages in dermatology: pathogenic roles and targeted therapeutics.

Authors:  Drew Kuraitis; Nadia Rosenthal; Erin Boh; Elizabeth McBurney
Journal:  Arch Dermatol Res       Date:  2021-02-28       Impact factor: 3.017

Review 3.  CRNDE: an oncogenic long non-coding RNA in cancers.

Authors:  Ya Lu; Huanhuan Sha; Xun Sun; Yuan Zhang; Yang Wu; Junying Zhang; Hui Zhang; Jianzhong Wu; Jifeng Feng
Journal:  Cancer Cell Int       Date:  2020-05-12       Impact factor: 5.722

4.  miR-205 inhibits the development of hypertrophic scars by targeting THBS1.

Authors:  Dongwen Jiang; Bingyu Guo; Feng Lin; Shixiu Lin; Kai Tao
Journal:  Aging (Albany NY)       Date:  2020-11-13       Impact factor: 5.682

Review 5.  Comprehensive Review on the Clinical Relevance of Long Non-Coding RNAs in Cutaneous Melanoma.

Authors:  Vincenzo De Falco; Stefania Napolitano; Daniela Esposito; Luigi Pio Guerrera; Davide Ciardiello; Luigi Formisano; Teresa Troiani
Journal:  Int J Mol Sci       Date:  2021-01-25       Impact factor: 5.923

Review 6.  CRNDE: A valuable long noncoding RNA for diagnosis and therapy of solid and hematological malignancies.

Authors:  Xuefei Ma; Wen Jin; Chaoxian Zhao; Xuefeng Wang; Kankan Wang
Journal:  Mol Ther Nucleic Acids       Date:  2022-03-09       Impact factor: 8.886

7.  Ovarian cancer cell-secreted exosomal miR-205 promotes metastasis by inducing angiogenesis.

Authors:  Liuqing He; Wei Zhu; Quan Chen; Yishu Yuan; Yixuan Wang; Junpu Wang; Xiaoying Wu
Journal:  Theranostics       Date:  2019-10-18       Impact factor: 11.556

Review 8.  CCL18 in the Progression of Cancer.

Authors:  Jan Korbecki; Mateusz Olbromski; Piotr Dzięgiel
Journal:  Int J Mol Sci       Date:  2020-10-26       Impact factor: 5.923

9.  lncRNA CRNDE is Upregulated in Glioblastoma Multiforme and Facilitates Cancer Progression Through Targeting miR-337-3p and ELMOD2 Axis.

Authors:  Jian Gao; Qunbang Chen; Yingjia Zhao; Ruizhe Hou
Journal:  Onco Targets Ther       Date:  2020-09-16       Impact factor: 4.147

Review 10.  The pleiotropic roles of circular and long noncoding RNAs in cutaneous melanoma.

Authors:  Barbara Montico; Giorgio Giurato; Giovanni Pecoraro; Annamaria Salvati; Alessia Covre; Francesca Colizzi; Agostino Steffan; Alessandro Weisz; Michele Maio; Luca Sigalotti; Elisabetta Fratta
Journal:  Mol Oncol       Date:  2021-06-18       Impact factor: 6.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.